The Market Online - At The Bell

Join our daily newsletter At The Bell to receive exclusive market insights

  • Zeotech (ZEO) receives a more than $1 million refund under the Australian Government’s research and development tax incentive program
  • The company was reimbursed for expenditure on the development of its proprietary mineral processing technology to sustainably produce manufactured zeolites
  • The rebate also relates to advancements of the company’s dual stream agri-soil product development and carbon utilisation technology
  • Managing Director Peter Zardo says the funds position the company well to continue progressing scaled up production and development of its technology
  • ZEO shares last traded at 4.2 cents on January 18

Zeotech (ZEO) has received a refund of over $1 million under the Australian Government’s research and development tax incentive program.

The Federal Government’s program provides a cash refund on eligible research and development activities performed by Australian companies.

Zeotech was granted $1,041,486.50 back for the funds it spent on the development of its proprietary mineral processing technology to sustainably produce manufactured zeolites.

Additionally, the rebate relates to advancements of the company’s dual stream agri-soil product development, which includes soil carbon protection and enhancement, as well as carbon utilisation technology.

The company’s Managing Director, Peter Zardo, praised the Government incentive which he said supports Australian innovation.

“The funds received in conjunction with cash on hand, position the company well to continue progressing scaled up production and development of innovative applications for manufactured zeolites revolving around circularity and greenhouse gas mitigation.”

ZEO shares last traded at 4.2 cents on January 18.

ZEO by the numbers
More From The Market Online

Whitebark launches $1.5M capital raise to progress QLD geothermal assets

Whitebark Energy Ltd has launched a capital raise totalling A$1.5M to fund development of its geothermal…

Week 24 Wrap: US contagion sentiment not so contagious; iron ore remains pressured

It was, overall, a lacklustre week for the ASX. We only saw one green day on…

Proteomics appoints Growth Medics to drive European sales

Proteomics International Laboratories has engaged Growth Medics B.V., to assist with the selection of EU alliance…

Gillon McLachlan takes the reins as Tabcorp MD & CEO

Former AFL BOSS Gillon McLachlan has been appointed the new Managing Director and Chief Executive Officer…